This is not the most recent version of the article. View current version (8 DEC 2010)

Intervention Protocol

Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter related infections in children with cancer

  1. Ramandeep S Arora1,*,
  2. Rebecca Roberts2,
  3. Tim OB Eden3,
  4. Barry Pizer4

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 15 APR 2009

DOI: 10.1002/14651858.CD007785

How to Cite

Arora RS, Roberts R, Eden TOB, Pizer B. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter related infections in children with cancer (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007785. DOI: 10.1002/14651858.CD007785.

Author Information

  1. 1

    Royal Manchester Children's Hospital, Cancer Research UK Paediatric and Familial Research Group, Manchester, Lancashire, UK

  2. 2

    University of Manchester, Manchester, UK

  3. 3

    Christie Hospital NHS Trust, Young Oncology Unit, Manchester, UK

  4. 4

    Royal Liverpool Children's Hospital NHS Trust, Oncology Unit, Liverpool, UK

*Ramandeep S Arora, Cancer Research UK Paediatric and Familial Research Group, Royal Manchester Children's Hospital, Hospital Road, Manchester, Lancashire, M27 4HA, UK. reemaraman@doctors.org.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (08 DEC 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary aim is to find which interventions (other than anticoagulants, systemic antibiotics and antibiotic lock techniques) are effective in preventing central venous catheter (CVC) related infections in children with cancer.

Further objectives are to examine the effectiveness of each intervention (for details see the section 'Types of interventions') across the following subgroups:

  1. those with implanted versus external catheters;
  2. those with haematological versus non-haematological malignancies; and
  3. those children with cancer who have undergone haematopoietic stem cell transplant (HSCT) versus those who have not.